Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article (62)

Advertisement

Research Article Free access | 10.1172/JCI105950

Altered sulfhydryl reactivity of hemoglobins and red blood cell membranes in congenital heinz body hemolytic anemia

Harry S. Jacob, Michael C. Brain, and John V. Dacie

Medical Research Council Group for Research in Haemolytic Mechanisms, Royal Postgraduate Medical School, London, England

St. Elizabeth's Hospital and Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts 02111

Find articles by Jacob, H. in: PubMed | Google Scholar

Medical Research Council Group for Research in Haemolytic Mechanisms, Royal Postgraduate Medical School, London, England

St. Elizabeth's Hospital and Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts 02111

Find articles by Brain, M. in: PubMed | Google Scholar

Medical Research Council Group for Research in Haemolytic Mechanisms, Royal Postgraduate Medical School, London, England

St. Elizabeth's Hospital and Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts 02111

Find articles by Dacie, J. in: PubMed | Google Scholar

Published December 1, 1968 - More info

Published in Volume 47, Issue 12 on December 1, 1968
J Clin Invest. 1968;47(12):2664–2677. https://doi.org/10.1172/JCI105950.
© 1968 The American Society for Clinical Investigation
Published December 1, 1968 - Version history
View PDF
Abstract

The mechanisms of hemoglobin precipitation into Heinz bodies and hemolytic anemia that characterize congenital Heinz body hemolytic anemia (CHBHA) were studied in patients with the unstable hemoglobins, Köln (β-98 valine → methionine) and Hammersmith (β-42 phenylalanine → serine). The cysteines in the 93rd position of the β-chains of CHBHA hemoglobins bound glutathione excessively in mixed disulfide linkage. The resulting diminished “free” GSH within the cell accelerated hexose monophosphate shunt metabolism. The unique precipitability of CHBHA hemoglobins when heated at 50°C could be induced in normal hemoglobin A by artificially blockading its sulfhydryl groups with paramercuribenzoate (PMB).

Reflecting the previously reported excessive flux of hemes from hemoglobin Köln, the expected heme/globin ratio in this hemoglobin was reduced by 30%. The further increment in heme loss that occurs with heat (50°C) underlies the unique heat precipitability of CHBHA hemoglobins; it was retarded if detachment of heme was inhibited by cyanide or carbon monoxide.

Heinz bodies were attached to red cell membrane thiol groups presumably through mixed disulfide bonds, being released by mercaptoethanol. Binding of hemoglobin Köln-59Fe to red cell ghosts, which was markedly enhanced when Heinz bodies were generated at 50°C, was inhibited if membrane thiols were preblockaded by PMB. The depletion of membrane thiols by their reaction with Heinz bodies rendered CHBHA red cells hypersusceptible to membrane sulfhydryl inhibitors, as manifested by inordinate cation leakage, osmotic fragility, and autohemolysis.

We conclude that both cellular and membrane thiols bind β-93 sulfhydryls of CHBHA hemoglobins as mixed disulfides. Concomitantly, heme avidity to β-92 lessens, suggesting that degradation of the resulting excessively freed heme may produce the pigmented dipyrroluria of this syndrome. Heinz bodies, reflecting the heightend precipitability of heme-deficient globin, attach to, thereby depleting, membrane sulfhydryl groups. This, as shown previously, could underlie the hemolytic anemia of this syndrome by causing membrane hyperpermeability, premature splenic entrapment, and ultimately osmotic destruction of red blood cells.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 2664
page 2664
icon of scanned page 2665
page 2665
icon of scanned page 2666
page 2666
icon of scanned page 2667
page 2667
icon of scanned page 2668
page 2668
icon of scanned page 2669
page 2669
icon of scanned page 2670
page 2670
icon of scanned page 2671
page 2671
icon of scanned page 2672
page 2672
icon of scanned page 2673
page 2673
icon of scanned page 2674
page 2674
icon of scanned page 2675
page 2675
icon of scanned page 2676
page 2676
icon of scanned page 2677
page 2677
Version history
  • Version 1 (December 1, 1968): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article (62)

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts